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Abstract
Tip60 is a histone acetyltransferase (HAT) involved in the acetyltransferase activity and the cellular response to DNA
damage. Here, we show that programmed cell death 5 (PDCD5), a human apoptosis-related protein, binds to Tip60
and enhances the stability of Tip60 protein in unstressed conditions. The binding amount of PDCD5 and Tip60 is
significantly increased after UV irradiation. Further, PDCD5 enhances HAT activity of Tip60 and Tip60-dependent
histone acetylation in both basal and UV-induced levels. We also find that PDCD5 increases Tip60-dependent
K120 acetylation of p53 and participates in the p53-dependent expression of apoptosis-related genes, such as
Bax. Moreover, we demonstrate the biological significance of the PDCD5-Tip60 interaction; that is, they function
in cooperation to accelerate DNA damage–induced apoptosis and knockdown of PDCD5 or Tip60 impairs their
apoptosis-accelerating activity, mutually. Consistent with this, PDCD5 levels increase significantly on DNA damage
in U2OS cells, as does Tip60. Together, our findings indicate that PDCD5 may play a dual role in the Tip60 pathway.
Specifically, under normal growth conditions, PDCD5 contributes to maintaining a basal pool of Tip60 and its HAT
activity. After DNA damage, PDCD5 functions as a Tip60 coactivator to promote apoptosis.
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Introduction
Tip60 was originally identified as a protein that interacts with human
immunodeficiency virus–Tat and increases Tat-dependent transcription
[1]. Later studies demonstrated that Tip60 possesses histone acetyl-
transferase (HAT) activity in vivo and in vitro and that the role of
Tip60 in transcriptional regulation has been intensively investigated
[2–4]. Accumulated data suggest that Tip60 exerts diverse biological
functions through mechanisms that are either dependent or indepen-
dent of its intrinsic HATactivity, such as cellular signaling, DNA dam-
age repair, cell cycle, checkpoint control, and apoptosis [5]. Tip60 is a
tightly regulated transcriptional coregulator, acting in a large, multi-
protein complex, with a range of transcription factors, including the
androgen receptor [6], Myc [7], STAT3 [8], nuclear factor κB [9],
E2F1 [10,11], and p53 [12–14]. Tip60-mediated regulation typically
involves recruitment of Tip60 acetyltransferase activity to chromatin.
Additionally, in response to DNA double-strand breaks, Tip60 is re-
cruited to DNA lesions, where it participates in both the initial and
the final stages of repair [15].
Programmed cell death 5 (PDCD5), formerly referred to as TF-1
cell apoptosis-related gene 19 (TFAR19), is a novel gene first cloned
in our laboratory [16]. Previous studies have showed that PDCD5 can
facilitate apoptosis and enhance TAJ/TROY–induced paraptosis–like
cell death [17]. The PDCD5 protein is upregulated in cells undergo-
ing apoptosis, where it translocates rapidly from the cytoplasm to the
nucleus [18]. Recent studies have confirmed that two single-nucleotide
polymorphisms, with linkage disequilibrium in the human PDCD5
gene 5′-regulatory region, affect promoter activity and the susceptibility
of a Chinese population to develop chronic myelogenous leukemia
[19]. In addition, a single-nucleotide polymorphism in the 5′-upstream
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region of PDCD5 is predictive of lung cancer risk and prognosis [20],
suggesting that PDCD5 may represent a novel tumor suppressor gene
influencing lung cancer.
The levels of both mRNA and protein of PDCD5 were analyzed in
human carcinomas by different techniques. Decreased PDCD5 expres-
sion has been reported in various human tumors, such as breast cancer
[21], hepatocellular carcinoma [22], lung cancer [20], gastric cancer
[23], chronic myelogenous leukemia [24], and astrocytic gliomas [25].
These findings, together with our studies, suggest that decreased PDCD5
expression may be associated with carcinoma formation and malignant
progression. Nevertheless, the molecular mechanism by which PDCD5
accelerates cell apoptosis remains unknown, as do the downstream events
after PDCD5 nuclear accumulation in early apoptosis.
PDCD5 was recently implicated as a novel binding partner of
Tip60, through a large-scale yeast two-hybrid screen [26]. However,
there has yet to be no experimental evidence reported in mammalian
cells or further functional investigation. In this study, we demonstrate
for the first time that PDCD5 interacts with Tip60 in mammalian
cells, enhances the stability of Tip60, and inhibits its proteasome-
dependent degradation. After DNA damage, PDCD5 can accelerate
the Tip60-mediated apoptotic cell responses. We thus conclude that
PDCD5 is a positive regulator of Tip60.
Materials and Methods
Plasmids, siRNA, and Antibodies
The pcDNA3-PDCD5 and pcDNA3-PDCD5-myc plasmids used
have been described previously [17]. The pCMV5-Tip60 and pCMV5
Flag-HA-Tip60 vectors were kindly provided by Dr. Amati Bruno.
PcDNA3-Flag-p53 vector was a gift from Dr. Steven B. McMahon.
All siRNA including PDCD5, Tip60, and the control siRNAwere syn-
thesized by GeneChem Corporation (Shanghai, China); the sequences
of the various siRNA have been reported previously [13,27]. The anti-
Flag, antimyc, and antiactin antibodies were purchased from Sigma
(St. Louis, MO). The anti-Tip60 and anti-p53 were from Santa Cruz
Biotechnology (Santa Cruz, CA). The anti–acetyl H2A (Lys5), anti–
acetyl H4 (Lys8), anti–total H2A, and anti–PARP antibodies were from
Cell Signaling Technology (Beverly, MA). The anti–pan–acetyl-lysine
antibody, anti–acetyl H3 (Lys14), and anti-Bax were from Upstate
(Waltham, MA). The anti–acetyl k120-p53 antibody was kindly pro-
vided by Dr. Steven B. McMahon. The mouse anti-PDCD5 mono-
clonal antibody (3A3), rabbit anti-PDCD5 polyclonal antibody, and
FITC-labeled anti-PDCD5 antibody have been described previously
[18]. IRDye 800–conjugated secondary antibodies against mouse,
rabbit, and goat IgG were purchased from Li-Cor Bioscience (Lincoln,
NE). TRITC-labeled rabbit against goat IgG was from Zhongshan
Corporation (Beijing, China).
Cell Culture, Transfection, and Treatment
U2OS, H1299, and HeLa cell lines were cultured in Dulbecco’s
modified Eagle’s medium, supplemented with 10% fetal bovine
serum. HeLa cells were transfected by electroporation, as described
previously [27]; U2OS and H1299 cell lines were transfected using
Lipofectamine 2000 (Invitrogen, Life Technologies, Inc., Carlsbad,
CA) according to the manufacturer’s protocol.
Proteasome inhibition was achieved by treating cells with 100 μM
of N -acetyl-Leu-Leu-norleucine (ALLN; Sigma) or 10 μM of MG132
(Sigma) for 12 hours. Protein acetylation was enhanced by a 4-hour
treatment of the cells with 10 mM of sodium butyrate (Sigma) before
cell lysis. Protein translation inhibition was achieved by treating cells
with 100 μg/ml of cycloheximide (CHX; Sigma) for different times
(Figure 3C ). Apoptosis was induced with various concentrations of
actinomycin D (Act.D; 100 and 500 nM) or doxorubicin (Doxo;
0.25 and 1 μg/ml). UV irradiation (20 J/m2) was performed using a
CX-2000 UV cross-linker (UVP, Inc., Upland, CA).
Immunoprecipitation and Western Blot
For the immunoprecipitation (IP) experiment, cells were collected
and lysed in lysis buffer (300 mM NaCl, 50 mM Tris pH 8.0, 0.4%
NP-40, 10 mM MgCl2, and 2.5 mM CaCl2) supplemented with
protease inhibitors (Complete mini EDTA-free; Roche Diagnostics,
Mannheim, Germany). After centrifugation, the supernatant was
measured using the BCA protein assay reagent (Pierce, Rockford, IL).
Then, 1 mg of total cell extracts were diluted to 1 ml of dilution buffer
(50 mM Tris, pH 8.0, 0.4% NP-40). After a precleaning step with pro-
tein G sepharose beads, cell lysates were incubated with appropriate anti-
bodies overnight at 4°C and then with 50 μl of a 50% slurry of protein G
sepharose for 2 hours. Immunoprecipitates were then washed five
times in washing buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 0.4%
NP-40, and 5 mMMgCl2) and analyzed by Western blot, as described
previously [27]. The protein bands were visualized using an IRDye
800CW-conjugated secondary antibody; the infrared fluorescence
image was obtained using an Odyssey infrared imaging system (Li-Cor
Bioscience). In some experiments, we performed coimmunoprecipita-
tion (CoIP) by using One-Step Complete IP-Western Kit (GeneScript
Corporation, Piscataway, NJ) according to the manufacturer’s protocol.
Glutathione S -Transferase Pull-down
Recombinant glutathione S-transferase (GST) or GST-PDCD5 were
expressed in Escherichia coli and purified. In addition, the amounts of
recombinant proteins were assessed by SDS-PAGE. Then, 1 μg of
GST fusion proteins or GSTwas incubated with whole cell lysates ex-
tracted from Flag-HA-Tip60–transfected HeLa cells overnight at 4°C.
After five washes, beads were resuspended in 2× SDS loading buffer
and analyzed by SDS-PAGE followed by Western blot.
Immunofluorescence Analysis
U2OS cells were plated on glass coverslips and then transfected
with pCMV5-Tip60 plasmid using Lipofectamine 2000. 24 hours
after transfection, cells were treated with or without UV irradiation
(20 J/m2) for 5 hours. Cells were then fixed in PBS supplemented
with 4% paraformaldehyde for 15 minutes at 4°C, and permeabilized
in PBS supplemented with 0.2% Triton X-100 for 30 minutes. After
a 30-minute incubation in blocking buffer (3% BSA in PBS), cells
were incubated with goat anti-Tip60 antibodies for 1 hour at 4°C,
then incubated with TRITC-conjugated rabbit antigoat IgG and
FITC-labeled mouse anti-PDCD5 for 1 hour. 4′,6-Diamidino-2-
phenylindole (DAPI; Sigma) was used to counterstain the nuclei.
After several washing, coverslips were observed under a Leica SP2
confocal system (Germany).
Real-time Polymerase Chain Reaction Analysis
U2OS cells were transfected with either siPDCD5 or control siRNA
with Lipofectamine 2000. Thirty-six hours later, total RNA were ex-
tracted from transfected U2OS cells using TRIzol reagent (Invitrogen)
according to the manufacturer’s instructions. First-strand cDNA was
generated using the total RNA in a standard reverse transcriptase re-
action using a poly(dT) oligonucleotide as a primer and SuperScript II
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reverse transcriptase (Invitrogen, Life Technologies, Inc.). The cDNA
were then subjected to real-time polymerase chain reaction (PCR) analy-
sis. The primers used in the assay are available on request.
IP-HAT Assay
This assay was performed essentially as described previously [28].
Briefly, HeLa cells were cotransfected with Flag-HA-Tip60 and
PDCD5 plasmids or empty vector. Thirty-six hours after transfection,
cells were harvested and IP was performed with an anti-Flag antibody.
After the last wash, the supernatant was completely aspirated, and the
pelleted beads were resuspended in 30μl ofHATreaction buffer (50mM
Tris/HCl, pH 8.0, 10% glycerol, 1 mM DTT, 1 mM PMSF, and
0.1 mMEDTA) containing 2.5 μg of histone 4 (New England BioLabs,
Ipswich, MA), 10 mM sodium butyrate, and 50 nCi 3H-labeled acetyl-
CoA (Amersham Pharmacia, Little Chalfont, United Kingdom). The
reaction mixture was incubated at 30°C for 60 minutes. Then, the
mixture was spotted onto Whatman P81 phosphocellulose squares
(2 × 2 cm) and allowed to air dry. Dry filters were washed three
times for 2 minutes at room temperature with 200 mM sodium bi-
carbonate (pH 9.2) to remove unincorporated radioactive acetyl-CoA.
The filters were then placed in scintillation vials, and 2 ml of scintilla-
tion fluid was added. After incubating the vials at room temperature
for 10 minutes, the amount of incorporated radioactivity was deter-
mined using a liquid scintillation counter.
Detection of Phosphatidylserine Externalization
Treated cells (5 × 105) were trypsinized, washed twice with PBS,
and resuspended in 200 μl of binding buffer (10 mM HEPES, pH
7.4, 140 mM NaCl, 1 mMMgCl2, 5 mM KCl, and 2.5 mM CaCl2).
FITC-conjugated Annexin V was added to a final concentration of
0.5 μg/ml according to the manufacturer’s instructions (Beijing Biosea,
China). After 20 minutes of incubation at room temperature in the
dark, 400 μl of binding buffer was added, and samples were immedi-
ately analyzed on a FACSCalibur flow cytometer (Becton Dickinson,
San Jose, CA).
Results
PDCD5 Interacts with Tip60
To confirm the association of Tip60 and PDCD5 inmammalian cells,
Flag-HA-Tip60 and myc-PDCD5 plasmids were cotransfected into
HeLa cells. Cell lysates were subjected to IP with an antimyc antibody.
Figure 1. PDCD5 interacts with Tip60. (A) Coimmunoprecipitation of Tip60 and PDCD5 in HeLa cells. Cells were cotransfected with Flag-
HA-Tip60 and myc-PDCD5 plasmids. Total cell extracts were subjected to IP using either an antimyc or an irrelevant control IgG, as
indicated. Immunoprecipitated proteins were then analyzed for the presence of FH-Tip60 by Western blot. (B) Cells were treated the
same as in (A), except that cell extracts were immunoprecipitated with an anti-Flag antibody and immunoblotted with an antimyc anti-
body. (C) Endogenous PDCD5 interacts with Tip60 in U2OS cells. Total cell extracts were subjected to IP using either an anti-PDCD5 or
an irrelevant control IgG, as indicated. Immunoprecipitated proteins were then analyzed for the presence of Tip60 by Western blot. (D)
As in (C), except that cell extracts were immunoprecipitated with an anti-Tip60 antibody and immunoblotted with an anti-PDCD5 anti-
body. (E) Tip60 association with endogenous PDCD5 is increased after UV irradiation. U2OS cells were treated with or without UV
irradiation (20 J/m2) for 5 hours. Coimmunoprecipitation was performed by using One-Step Complete IP-Western Kit. (F) Direct interac-
tion of PDCD5 with Tip60 in vitro. The full-length GST-PDCD5 fusion protein (lane 3) and the GST protein (lane 2) were incubated with
Tip60-transfected HeLa cell lysates overnight at 4°C. Washed beads were analyzed for the presence of Tip60 and GST by Western blot.
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Western blot analysis revealed that Flag-HA-Tip60 coprecipitated with
myc-PDCD5 (Figure 1A). Reciprocally, myc-PDCD5 was detected in
the Flag-HA-Tip60 immunoprecipitates (Figure 1B), demonstrating
that the two proteins existed in a complex in HeLa cells.
Because the above experiments relied on overexpressed protein, we
sought to examine whether interaction occurs between endogenous
PDCD5 and Tip60. Endogenous CoIP analysis provided evidences
for the endogenous PDCD5-Tip60 interaction (Figure 1, C and D).
It is known that Tip60 can be induced and upregulated by UV irra-
diation [29]. Thus, we further tested the PDCD5-Tip60 interaction
in UV-treated cells using One-Step Complete IP-Western Kit accord-
ing to the manufacturer’s protocol. This assay revealed that the amount
of Tip60 bound to PDCD5 significantly increased after UV irradia-
tion (Figure 1E ). This interaction was specific because control IgG
failed to bind either Tip60 or PDCD5 (Figure 1, A–D). The inter-
action between PDCD5 and Tip60 can also be observed by using a
pull-down approach (Figure 1F). These findings suggest that PDCD5
directly interacts with Tip60, and the association of the two proteins is
upregulated after UV irradiation. Because endogenous Tip60 protein
as difficult to be detected by Western blot, the lysates of Flag-HA-
Tip60 transfected HeLa cells were taken as positive controls (Figure 1,
C , E , lane 1).
PDCD5 Colocalizes with Tip60
To further confirm the PDCD5-Tip60 association, we performed
the colocalization assay. Owing to the very low expression level of
Tip60, U2OS cells were transfected with pCMV5-Tip60 plasmids
for 24 hours, then treated with or without UV irradiation (20 J/m2),
and incubated for a further 5 hours before harvesting. Then, U2OS
cells were incubated with goat anti-Tip60, followed by an anti-
goat TRITC-conjugated antibody and FITC–anti-PDCD5. Cell nu-
cleus morphology was observed by DAPI staining. PDCD5 and
Tip60 colocalized and showed a relatively diffuse nuclear distribution
pattern in U2OS cells without UV irradiation (Figure 2, upper panel ).
Strikingly, in UV-treated U2OS cells, the localization of PDCD5 and
Tip60 converted to large nuclear speckles, and the distribution of
PDCD5 overlapped that of Tip60 (Figure 2, lower panel). The colocali-
zation assay confirms the interaction between PDCD5 and Tip60.
The nuclear localization of Tip60 has been studied extensively and
displayed large nuclear speckles [13,30,31] just as our results. Cheng
et al. [32] reported that Tip60 translocated to promyelocytic leuke-
mia (PML) bodies during DNA damage. We have even investigated
the colocalization of PDCD5/Tip60 and PML. It was found that the
speckles of PDCD5/Tip60 were larger than PML bodies (data not
showed). The inducible formation of the Tip60-PDCD5 larger
speckles may indicate that the degree of PDCD5’s colocalization with
Tip60 was increased under UV irradiation. This evidence supported
that both proteins could act in similar regulatory pathways and play
an important role in nucleus in the response to DNA damage.
PDCD5 Enhances the Stability of the Tip60 Protein
To assess the role of the PDCD5-Tip60 association, we monitored
the changes in the levels of Tip60 when PDCD5 was overexpressed
or depleted. U2OS cells were cotransfected for 36 hours with Tip60
and either PDCD5 or specific siRNA against PDCD5 that we had
previously characterized [27]. Western blot indicated the Tip60 pro-
tein levels showed a weak increase in coexpressing PDCD5 cells com-
pared with cells transfected with empty vector (Figure 3A, left panel ).
Meanwhile, Tip60 protein levels decreased dramatically 36 hours after
knockdown of endogenous PDCD5, whereas actin levels were un-
changed (Figure 3A, right panel). This experiment has been performed
five times at least, and the results were same.
We further examined the mRNA levels of Tip60 after treatment
with siRNA against PDCD5. U2OS cells were transfected for 36 hours
with either siPDCD5 or control siRNA and then cells were harvested
and analyzed by real-time PCR. As shown in Figure 3B, knockdown
of PDCD5 failed to influence the mRNA levels of Tip60, indicating
that PDCD5 might not regulate Tip60 on the transcription level. We
next tested the influence of PDCD5 on Tip60 half-life. U2OS cells
were transiently cotransfected with Tip60 and either siRNA against
PDCD5 or control siRNA. Cells were then treated with the transla-
tion inhibitor CHX (100 μg/ml) for different periods as indicated.
As shown in Figure 3C , depletion of endogenous PDCD5 was asso-
ciated with a significant acceleration in Tip60 decay, which suggested
that the decrease of Tip60 protein levels after PDCD5 knockdown was
due to the destabilization of the Tip60 protein.
Figure 2. PDCD5 colocalizes with Tip60 in U2OS Cells. U2OS cells were transfected with the Tip60 plasmid and treated with or without UV
irradiation (20 J/m2, 5 hours). Immunofluorescence analysis was performed as described in the Materials and Methods Tip60 expression
was detected with anti-Tip60 antibody followed by an antigoat TRITC–conjugated secondary antibody. PDCD5 was detected by FITC–
anti-PDCD5. Cell nuclei were stained with DAPI. They were observed using Leica SP2 confocal microscope. Scale bar, 8 μm.
348 PDCD5 Accelerates Tip60-mediated Apoptosis Xu et al. Neoplasia Vol. 11, No. 4, 2009
It is known that Tip60 are degraded through the proteasome path-
way [29], so a series of experiments were conducted to investigate the
proteasomal degradation targeting of Tip60 by PDCD5. We added
the proteasome inhibitor ALLN (100 μM) or MG-132 (10 μM) to
treat U2OS cells. The data obtained from Western blot showed that
depletion of endogenous PDCD5 reduced Tip60 expression (Fig-
ure 3D, lane 1), which was consistent with the above observation.
However, after treatment with the ALLN or MG-132 for 12 hours,
the reduction in Tip60 levels was significantly blocked (Figure 3D,
lanes 3 and 5) compared with lane 1. This suggested that the protea-
some inhibitor (ALLN or MG-132) could rescue siPDCD5-mediated
degradation of the Tip60, indicating that endogenous PDCD5 may be
involved in the modulation of Tip60 levels in normal growing cells by
protecting Tip60 from proteasomal degradation.
Interestingly, when performing these experiments, we observed
that coexpression of Tip60 caused an increase in PDCD5 accumu-
lation (Figure 3E ). Knockdown of endogenous of Tip60 consistently
decreased the PDCD5 protein level (Figure 3F ), indicating that these
two proteins were mutually regulated in normal growing cells.
PDCD5 Promotes the HAT Activity of Tip60
We next sought to determine whether PDCD5 binding affects
Tip60 HAT activity using the IP-HAT assay. U2OS cells were co-
transfected with both Flag-HA-Tip60 and PDCD5 plasmids or
Flag-HA-Tip60 alone or an empty vector. Exogenous Tip60 pro-
tein was then immunoprecipitated with an anti-Flag antibody, and
the HAT activity present within the immunopellets was determined
using a liquid HAT assay [28]. Data from experiments showed that
compared with the pCDB group, the FH-Tip60 and cotransfected
groups had strong HAT activity (P < .01; Figure 4A). The difference
between the FH-Tip60 and cotransfected groups was statistically
Figure 3. PDCD5 enhances the stability of Tip60 protein. (A, left panel) Overexpression of PDCD5 increases the accumulation of Tip60.
U2OS cells were transfected with the indicated plasmids for 36 hours. Total cell extracts were analyzed for the presence of Tip60, PDCD5,
and actin by Western blot. (A, right panel) Knockdown of PDCD5 decreases the level of Tip60. U2OS cells were transfected with indicated
plasmids and siPDCD5 for 36 hours. Other treatments just were the same as left panel. (B) Knockdown of PDCD5 fails to influence the
mRNA level of Tip60. U2OS cells were transfected with siPDCD5 or control siRNA for 36 hours and then harvested and analyzed by real-
time PCR. Data are presented as mean ± SD. (C) Knockdown of PDCD5 accelerates the decay of Tip60. U2OS cells were transiently
cotransfected with Tip60 and either siPDCD5 or control siRNA. After 36 hours, cells were treated with 100 μg/ml of CHX for different
lengths of time as indicated. Total cell lysates were analyzed for the presence of Tip60 by Western blot. Relative Tip60 protein levels were
quantified using a Li-Cor Odyssey scanner (right panel). This experiment has been performed three times. The diagram presented is the
statistical analysis of a single representative experiment. (D) siPDCD5-mediated decreases of Tip60 levels are attenuated by proteasome
inhibition. U2OS cells were cotransfected with Tip60 and either siPDCD5 or control siRNA. After 24 hours, cells were treated with ALLN
(100 μM) or MG-132 (10 μM) for 12 hours. Total cell lysates were analyzed for the presence of Tip60, PDCD5, and actin by Western blot.
(E and F) Tip60 modulates PDCD5 expression. U2OS cells were transfected with the indicated plasmids (E) or siRNA (F) for 36 hours. Total
cell extracts were analyzed for the presence of PDCD5, Tip60, and actin by Western blot.
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significant (P < .05; Figure 4A), which indicated that PDCD5 could
enhance the HAT activity of Tip60 to some extent.
We further evaluated the effects of PDCD5 on histone acetylation
mediated by Tip60 in U2OS cells. As shown in Figure 4B (left panel ),
depletion of endogenous PDCD5 attenuated Tip60-mediated his-
tone acetylation, including lysine 5 of histone H2A, lysine 14 of his-
tone H3, and lysine 8 of histone H4. These effects remained the same
under the condition of UV irradiation (Figure 4B, right panel). These
findings indicate that the PDCD5-Tip60 interaction, at least in part,
is necessary for the modulation of Tip60 enzymatic activity in both
unstressed and stressed condition.
PDCD5 Promotes p53 Acetylation and p53-Dependent
Apoptosis-Related Gene Expression Mediated by Tip60
As we know, Tip60 is required for the acetylation of the endo-
genous p53 protein at K120 and for the p53-dependent induction
of proapoptotic target genes, such as Bax, in response to DNA dam-
age [33]. Hence, we next asked whether PDCD5 influenced either
acetylation of p53 or expression of p53-dependent apoptosis-related
genes mediated by Tip60. To examine this possibility, U2OS cells
were cotransfected with Tip60 and PDCD5 or an empty vector. Total
cell lysates were subjected to IP with a universal anti–acetyl-lysine anti-
body. A Western blot incubated with anti-p53 revealed that both
Tip60 (Figure 5A, lane 1) and PDCD5 alone (Figure 5A, lane 3) could
enhance the acetylation of p53 compared with the control vector
(Figure 5A). Coexpression of Tip60 and PDCD5 resulted in a weak
increase in the acetylation level of p53 (Figure 5A, lane 2).
We further detected the Tip60-dependent K120 acetylation of
p53 in H1299 cells, which lack an endogenous p53 expression. Cells
were cotransfected with Flag-p53 plasmid in the presence of PDCD5
or Tip60 or both. Total cell lysates were subjected to IP with an anti–
Ack 120–p53 antibody. Western blot probed with anti-p53 revealed
that the K120 acetylation level of exogenous p53 in H1299 was re-
markably increased in the presence of Tip60 (Figure 5B, lane 1).
PDCD5-transfected cells displayed a weak increase (Figure 5B, lane 3).
Coexpression of PDCD5 enhanced K120 acetylation of p53 (Fig-
ure 5B, lane 2), indicating that the interaction of PDCD5 and Tip60
had a synergistic effect on K120 acetylation of p53. Moreover, we tested
whether PDCD5 could enhance endogenous p53 acetylation at K120 in
response to DNA damage. U2OS cells were treated by UV irradiation,
the levels of p53 acetylation at K120 was increased in the presence of
Tip60 (Figure 5C , lane 2) compared with UV irradiation alone (Fig-
ure 5C , lane 4). Knockdown of endogenous PDCD5 resulted in a strik-
ing decrease of acetyl-K120 in the presence of Tip60 overexpression
(Figure 5C , lane 1). We also observed that depletion of endogenous
PDCD5 could attenuate the endogenous accumulation of acetyl-K120
(Figure 5C , lane 3). These data indicate that PDCD5 maybe an impor-
tant regulator in K120 acetylation of p53 after genotoxic stress.
Tip60-mediated acetylation of p53 at K120 is also a key for the acti-
vation of proapoptotic molecules, such as Bax, which is a mediator of
p53-dependent apoptosis. Thus, we next tested the effect of Tip60 on
Bax in U2OS cells in the presence or absence of PDCD5. Knockdown
of PDCD5 resulted in a decreased expression of Bax at the protein
level under the unstressed condition (Figure 5D, lane 1). When cells
were treated with UV irradiation, Act.D, and Doxo, the depressed Bax
expression was similar to the unstressed conditions in PDCD5-depleted
group (Figure 5D, lanes 3, 5, and 7). Together, these results indicate that
PDCD5 plays a positive role in Tip60-mediated p53 acetylation and
p53-dependent proapoptotic gene expression.
PDCD5 Is Required for Cell Apoptosis Induced by
DNA Damage
Our precious research has revealed that PDCD5 is related with apop-
tosis induced by DNA damage. Here, we detected endogenous PDCD5
expression in cells after DNA damage. After treatment with Act.D
(100 nM) and UV irradiation (20 J/m2) for different times in U2OS cells,
the PDCD5 protein exhibited a clear up-regulation, in a time-dependent
manner (Figure 6A). This phenomenon was consistent with the Tip60 ex-
pression described previously [34]. These data indicate that both PDCD5
and Tip60 are upregulated after DNA damage and that they may cooper-
ate to mediate the appropriate cellular response to DNA damage.
Next, we investigated whether the expression of PDCD5 is required
in apoptosis induced by DNA damage. PDCD5 expression was inhib-
ited using the specific PDCD5 siRNA, and the transfection efficiency
Figure 4. PDCD5 promotes the HAT activity of Tip60. (A) IP-HAT assay detects HAT activity. HeLa cells were cotransfected with Flag-HA-
Tip60 and PDCD5 plasmids or empty vector. Twenty-four hours after transfection, IPs were performed using an anti-Flag antibody, and the
pelleted immune complexes were tested for their ability to acetylate free histone H4. **P < .01; *P < .05. (B) Western blot analyses the
acetylation of histones. U2OS cells were cotransfected with the Tip60 plasmid and either siPDCD5 or control siRNA. After 24 hours, cells
were treated with or without UV irradiation for 12 hours and further incubated with 10 mM sodium butyrate for 4 hours. Then, histone
fractions were extracted, and immunoblots were probed with the indicated antibodies to determine the acetylation sites of the histone.
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Figure 6. PDCD5 is required for apoptosis induced by DNA damage. (A) PDCD5 expression was measured by Western blot in U2OS cells
treated with Act.D (100 nM) and UV irradiation (20 J/m2), as indicated. (B) U2OS cells were transfected with siPDCD5 or control siRNA for
24 hours and then further incubated with different concentration of Act.D and Doxo for 24 hours or UV-irradiated for the indicated time.
Then, cells were stained with FITC–Annexin V, and the percentage of cell apoptosis is shown. The data shown are from a representative
experiment. (C) Cell treatment was similar to (B). Western blots analyze the presence of PARP (full-length or cleaved) and actin.
Figure 5. PDCD5 promotes p53 acetylation and p53-dependent apoptosis-related gene expression mediated by Tip60. (A) U2OS cells
were cotransfected with Tip60 and either PDCD5 or empty vector for 36 hours. After 4 hours of treatment with 10 mM sodium butyrate,
total cell lysates were subjected to IPs with a pan–acetyl-lysine antibody. Precipitates were blotted with an anti-p53 antibody to detect
the p53 acetylation level. Input lysates were also blotted with anti-p53, anti-Tip60, anti-PDCD5, and antiactin antibodies. (B) H1299 cells
were cotransfected as indicated for 36 hours. After 4 hours of treatment with 10 mM sodium butyrate, total cell lysates were subjected
to IPs with an anti-Ack 120–p53 antibody. Precipitates were blotted with an anti-p53 antibody to detect K120 acetylation of p53. Input
lysates were also blotted with anti-p53 antibodies. (C) U2OS cells were transfected as indicated. After 24 hours, cells were given UV
irradiation for 12 hours. Immunoprecipitation and Western blot were performed as in (B). (D) U2OS cells were transiently cotransfected
with Tip60 and either siPDCD5 or control siRNA. After 24 hours, cells were treated with or without genotoxic treatments as indicated,
and then total cell lysates were analyzed for the presence of Bax, PDCD5, and actin by Western blot.
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achieved was more than 80% (data not shown). Then, U2OS cells
were treated with different doses of Act.D (100 and 500 nM), Doxo
(0.25 and 1 μg/ml), or 20 J/m2 of UV irradiation (12 and 24 hours).
Apoptotic activity was monitored by FITC–Annexin V staining and
caspase-mediated poly (ADP-ribose) polymerase (PARP) cleavage. As
expected, compared with control siRNA, knockdown of PDCD5 pro-
duced a significant resistance to DNA damage-induced apoptosis in
U2OS cells. This was indicated by the decrease of Annexin V–positive
cells (Figure 6B, lower panel ) and reduced PARP cleavage (Figure 6C).
These findings provide evidences of the direct involvement of PDCD5
in the apoptotic cell response after DNA damage.
Coexpression of PDCD5 and Tip60 Accelerates DNA
Damage-Induced Apoptosis
To investigate the functional significance of the targeting of Tip60
by PDCD5, a series of experiments were conducted. Our hypothesis
was that the PDCD5-Tip60 association might enhance the apoptotic
response of cells to genotoxic treatments, in which Tip60 has been
shown to be involved [4,34,35].
U2OS cells were transfected as indicated, and apoptosis was in-
duced by UV irradiation. Both PDCD5 and Tip60 alone could ef-
fectively promote U2OS apoptosis compared with empty vector after
UV irradiation (Figure 7A). Overexpression of both PDCD5 and
Tip60 produced a synergistic effect, as indicated by the increase of
Annexin V–positive cells (Figure 7A) and increased PARP cleavage
(Figure 7B). Moreover, knockdown of endogenous PDCD5 caused
inhibition of Tip60-dependent cell apoptosis, as indicated by the
decrease in Annexin V–positive cells (Figure 7C ) and reduced PARP
cleavage (Figure 7D, left panel). Conversely, we also observed that
knockdown of Tip60 impaired the apoptotic cell response mediated
by PDCD5 overexpression (Figure 7, C and D, right panel), indicat-
ing that the apoptosis-promoting effect of PDCD5 was, at least in
part, Tip60-dependent. On the basis of these data, we propose that
PDCD5 and Tip60 may regulate each other. It is thus tempting to
speculate that their activation and up-regulation are important events
involved in DNA damage–induced apoptosis and that both are re-
quired for this process.
Discussion
PDCD5 has been described as an apoptosis-promoting molecule.
Here, we provide evidences for the first time that PDCD5 is a novel
partner of the Tip60 protein, confirmed by CoIP, GST pull-down, and
colocalization assay. Data from our consistent experiments suggest that
PDCD5 can stabilize Tip60 levels and inhibit its proteasomal degra-
dation. PDCD5 may play an important role in the modulation of
Tip60 levels in normal growing cells by protecting Tip60 from pro-
teasomal degradation. This analysis of the underlying mechanism
has revealed new aspects of the regulation of cellular Tip60.
Figure 7. Coexpression of PDCD5 and Tip60 accelerate DNA damage–induced apoptosis. (A) U2OS cells were transfected with PDCD5
and Tip60 plasmids alone or together. After 24 hours, they were treated with UV irradiation for 12 hours. Then, cells were stained
with FITC–Annexin V, and the percentage of apoptosis was determined. The data shown are from a representative experiment. (B) Cell
treatment was the same as in (A). Western blots analyze the presence of PARP (full-length or cleaved) and actin. (C) U2OS cells were
transfected with the indicated siRNA and plasmids. After 24 hours, they were treated and analyzed as in (A). The data shown are from
a representative experiment. (D) As in (C), except that total cell extracts were analyzed by Western blot for the presence of PARP
(full-length or cleaved) and actin.
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The activity of HATs is important for the proper control of gene
expression. Accordingly, many mechanisms regulating their activity
have been described. One mechanism is through protein-protein in-
teractions. We showed that, in normal growing conditions and stressed
condition, suppressed endogenous PDCD5 could decrease Tip60-
mediated histone acetylation, including histone H2A, histone H3,
and histone H4. Consistent with this, an in vitro HAT assay further
confirmed that the interaction of PDCD5 with Tip60 enhanced the
HAT activity of Tip60. We have even performed the HAT assay with
purified recombinant PDCD5 protein; unfortunately, PDCD5 alone
has no obvious HAT activity (data not shown). Therefore, there was
a good relationship between the ability of PDCD5 to interact with
Tip60 and the promotion of its HAT activity. It is thus tempting to
speculate that PDCD5, through its capacity to interact with Tip60, may
act as an additional stability factor and further enhance the enzyme-
substrate interaction. This may also be one of the mechanisms by
which PDCD5 promotes programmed cell death.
Tip60 involvement in DNA repair and apoptosis in response to
DNA damage is complex and elaborately regulated by multiple factors
in mammalian cells. Our results indicated that PDCD5 expression
was upregulated and required for apoptosis induced by DNA damage
(Figure 6). Because the association between PDCD5 and Tip60 was
increased under stressed conditions, we further detected an apoptosis-
accelerating effect of PDCD5 on Tip60. Overexpression of PDCD5
can give cells a remarkable sensitivity to genotoxic treatments, and there
was a synergistic effect when PDCD5 and Tip60 were co-overexpressed.
Knockdown of endogenous PDCD5 could impair the Tip60-mediated
apoptotic response including phosphatidylserine externalization and
caspase-mediated PARP cleavage. These findings suggest that nuclear
accumulation of endogenous PDCD5 in the preapoptotic or early apop-
totic stage can enhance the PDCD5-Tip60 interaction and function as
a cofactor for the Tip60-dependent apoptotic response.
Published data [33,36] demonstrate that Tip60 interacts physi-
cally with p53 and increases the stability and acetylation level of p53.
Notably, Tip60-dependent acetylation of p53 at the K120 site is a key
for p53-dependent apoptosis, through regulating expression of apop-
tosis gene, such as Bax. Our results, together with others, indeed dem-
onstrate that Tip60 strongly induced K120 acetylation of exogenous
p53 in H1299 cells. Moreover, PDCD5 overexpression can enhance
this process, compared with Tip60 alone. Additionally, knockdown
of PDCD5 in U2OS cells reduced the expression level of K120 acetyla-
tion with or without Tip60 overexpression (Figure 5C). At same time,
depletion of PDCD5 also reduced the expression level of Bax protein
in the presence of Tip60. Thus, we suggest that the interaction of
PDCD5 and Tip60 in the nucleus may increase the acetyl-K120 form
of p53 specifically accumulating at proapoptotic target genes, promote
the ability of p53 to activate Bax expression, and subsequently increase
apoptosis. Interestingly, we also found that PDCD5 has a potential
ability to interact with p53 identified by GST pull-down assay (Fig-
ure W1). Our results raise the possibility that PDCD5, Tip60, and
p53 should form a ternary complex, and there is an interregulatory net-
work among them. PDCD5 plays a positive regulatory role in the
Tip60-p53-apoptosis pathway. This needs more investigation and evi-
dence in vitro and in vivo, especially evidences from PDCD5 transgenic
mice or PDCD5 knockout mice.
Tip60 may influence tumorigenesis in multiple ways [37]. A
recent report showed that Tip60, in both mice and humans, has
haploinsufficient tumor suppressor activity and is required for the
Myc-induced DNA damage response [38]. It has also been found
that the human Tip60 gene is a frequent target for monoallelic loss
in human lymphomas and head-and-neck and mammary carcino-
mas, with concomitant reduction in mRNA levels. In the present
study, immunohistochemical analysis demonstrated loss of nuclear
Tip60 staining in mammary carcinomas. These events correlated
with disease grade and frequently concurred with mutations in p53.
Regarding PDCD5, its expression level, at both the mRNA and pro-
tein levels, was lower in many carcinomas. We propose that decreased
PDCD5 may impair Tip60 stability and the Tip60-mediated DNA
damage response, thereby counteracting the Tip60-p53 apoptosis
pathway or a tumor suppressor pathway. Key levels of Tip60, manipu-
lated by PDCD5, are required to control incipient tumor cell devel-
opment, the failure of which may synergize with Tip60 mutations,
toward tumor progression.
Our findings are the first to demonstrate a role for PDCD5 in in-
terfering with the expression of cellular genes, through modulation
of the enzymatic activity of Tip60. PDCD5 may play a dual role in
the Tip60 pathway: under normal growth conditions, PDCD5 con-
tributes to maintaining a basal pool of Tip60 and HAT activity; after
DNA damage, PDCD5 functions as Tip60 coactivator to promote
apoptosis through the Tip60-p53 pathway. Further clarifying the rela-
tionship between the ectopic expression of PDCD5-Tip60 and carci-
nomas will be interesting.
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Figure W1. Direct interaction of PDCD5 with p53 in vitro. The full-
length GST-PDCD5 fusion protein (lane 3) and the GST protein
(lane 2) were incubated with whole cell lysates extracted from
Flag-p53–transfected HeLa cells overnight at 4°C. Washed beads
were resuspended in 2× SDS loading buffer and analyzed by SDS-
PAGE followed by Western blot.
